Get the Stockscreener App
8.12
25.31%
1.64
After Hours:
7.00
-1.12
-13.79%
Endra Life Sciences Inc stock is traded at $8.12, with a volume of 13.82M.
It is up +25.31% in the last 24 hours and up +71.31% over the past month.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
See More
Previous Close:
$6.48
Open:
$9.83
24h Volume:
13.82M
Relative Volume:
52.51
Market Cap:
$6.11M
Revenue:
-
Net Income/Loss:
$-8.82M
P/E Ratio:
-0.0117
EPS:
-691.4213
Net Cash Flow:
$-8.08M
1W Performance:
+30.76%
1M Performance:
+71.31%
6M Performance:
+120.65%
1Y Performance:
+10.48%
1-Day Range:
$7.40
$9.85
1-Week Range:
$5.85
$9.85
52-Week Range:
$2.90
$22.68
Endra Life Sciences Inc Stock (NDRA) Company Profile
Name
Endra Life Sciences Inc
Sector
Industry
Phone
734-335-0468
Address
3600 GREEN COURT, ANN ARBOR, MI
Compare NDRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
8.12 | 4.88M | 0 | -8.82M | -8.08M | -691.42 |
|
TMO
Thermo Fisher Scientific Inc
|
524.58 | 198.17B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
205.14 | 144.97B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
633.32 | 49.29B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
138.23 | 38.73B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
203.77 | 33.69B | 15.70B | 1.24B | 2.01B | 6.9036 |
Endra Life Sciences Inc Stock (NDRA) Latest News
ENDRA Life Sciences stock soars after securing $4.9M for crypto strategy - Investing.com
Why Is ENDRA Life Sciences Stock Soaring Monday?ENDRA Life Sciences (NASDAQ:NDRA) - Benzinga
What’s Driving The Rally In NDRA Stock Today? - Asianet Newsable
Biotech Meets Crypto: ENDRA Life Sciences (NDRA) Stock Skyrockets 33% — Analyst Target $50 - ts2.tech
Does ENDRA Life Sciences Inc. show high probability of reboundMarket Trend Review & Risk Managed Investment Strategies - newser.com
NDRA Stock Price Jumps: What’s Next? - timothysykes.com
Will ENDRA Life Sciences Inc. benefit from macro trendsPortfolio Gains Report & Daily Stock Trend Reports - newser.com
ENDRA Life Sciences (NDRA) Announces $4.9M Private Placement - GuruFocus
Chart overlay techniques for tracking ENDRA Life Sciences Inc.2025 Major Catalysts & Real-Time Sentiment Analysis - newser.com
ENDRA Life Sciences soars after securing $4.9 million funding - TradingView
ENDRA Life Sciences raises $4.9 million to launch cryptocurrency treasury By Investing.com - Investing.com Nigeria
ENDRA Life Sciences raises $4.9 million to launch digital asset treasury - Investing.com India
ENDRA Life Sciences raises $4.9 million to launch cryptocurrency treasury - Investing.com
ENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager Arca - Business Wire
Is now a turning point for ENDRA Life Sciences Inc.2025 Stock Rankings & Long-Term Investment Growth Plans - newser.com
Published on: 2025-10-10 09:20:30 - newser.com
Published on: 2025-10-10 05:59:56 - newser.com
Applying sector rotation models to ENDRA Life Sciences Inc.Quarterly Growth Report & Weekly High Return Opportunities - newser.com
Published on: 2025-10-09 06:12:38 - newser.com
Leading vs lagging indicators on ENDRA Life Sciences Inc. performance2025 Big Picture & Precise Entry and Exit Recommendations - newser.com
Measuring ENDRA Life Sciences Inc.’s beta against major indicesQuarterly Earnings Summary & Target Return Focused Stock Picks - newser.com
Live market analysis of ENDRA Life Sciences Inc.2025 Technical Overview & Free Risk Controlled Daily Trade Plans - newser.com
Has ENDRA Life Sciences Inc. found a price floorMarket Activity Recap & Target Return Focused Stock Picks - newser.com
Best data tools to analyze ENDRA Life Sciences Inc. stockJuly 2025 Movers & Safe Capital Growth Tips - newser.com
Head to Head Survey: Semler Scientific (NASDAQ:SMLR) vs. ENDRA Life Sciences (NASDAQ:NDRA) - Defense World
Is ENDRA Life Sciences Inc a good long term investmentMACD Trading Signals & Free Daily Stock Hotspot Analysis - earlytimes.in
Exit strategy if you’re trapped in ENDRA Life Sciences Inc.July 2025 Decliners & Target Return Focused Picks - newser.com
ENDRA Life Sciences Inc Stock Analysis and ForecastDouble Top/Bottom Patterns & Access Advanced Stock Screening Tools - earlytimes.in
Pattern recognition hints at ENDRA Life Sciences Inc. upsideWeekly Gains Summary & Growth Focused Stock Reports - newser.com
Understanding ENDRA Life Sciences Inc.’s price movementJuly 2025 Drop Watch & Free Weekly Watchlist of Top Performers - newser.com
How to escape a deep drawdown in GlycoMimetics Inc.Rate Hike & Fast Entry Momentum Trade Alerts - newser.com
ENDRA Life Sciences (NDRA) Analyst Rating Update: Target Price L - GuruFocus
Can trapped investors hope for a rebound in ENDRA Life Sciences Inc.Bull Run & Safe Capital Growth Plans - newser.com
Bear Alert: Is ENDRA Life Sciences Inc stock a top performer YTDWeekly Trade Summary & Growth Focused Stock Pick Reports - خودرو بانک
Volatility clustering patterns for ENDRA Life Sciences Inc.2025 Retail Activity & Free Accurate Trade Setup Notifications - newser.com
Will ENDRA Life Sciences Inc. see short term momentumJuly 2025 Short Interest & AI Powered Buy and Sell Recommendations - newser.com
How to escape a deep drawdown in ENDRA Life Sciences Inc.2025 Investor Takeaways & Capital Efficiency Focused Strategies - newser.com
Endra Life Sciences Inc Stock (NDRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.61%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):